FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557974562> ?p ?o ?g. }

• W2557974562 abstract "Abstract Nucleophosmin (NPM1) gene mutations represent the most common genetic alterations in adult acute myeloid leukemia (AML), accounting for about 30% of cases and 50–60% of AML with normal karyotype. In addition to their recognized prognostic value (when combined with analysis of the FLT3 gene), NPM1 mutations represent an ideal marker for monitoring of minimal residual disease (MRD) since they are very stable during the course of the disease. PCR quantitative monitoring of NPM1 mutant copies has been mainly restricted to patients treated with conventional chemotherapy. In our study, we retrospectively analyzed, by RQ-PCR, MRD in 12 consecutive NPM1-mutated AML patients who underwent an autologous peripheral blood stem cell transplantation (PBSCT) between September 2000 and March 2008 at the Division of Hematology, “Sapienza” University of Rome. By sequencing of the region encompassing NPM1 exon 12, we demonstrated the presence of a type A mutation in 10/12 patients and of a type B in the remaining 2. Moreover, at diagnosis molecular analysis of the FLT3 gene revealed an internal tandem duplication (ITD) in 7/12 patients. Cytogenetic analysis showed a normal karyotype in 11/12, whereas 1 patient presented a minor karyotype aberration (trisomy 4). RQ-PCR was retrospectively performed on bone marrow samples in all patients at diagnosis, in 11/12 patients before the transplant and in 9/12 after the graft. Six of the 12 patients are at present in continuous complete remission (CCR) with a median follow-up of 54 months (range 4–89), 1 patient has died in CCR 55 months after PBSCT due to a pancreatic carcinoma and 5/12 have relapsed. Four of the latter 5 patients relapsed shortly after the transplant (range 3–10 months); 2 of them died of disease progression and 2 of salvage chemotherapy toxicity. One patient, who relapsed 92 months from PBSCT, is alive in second hematological remission following re-induction and consolidation chemotherapy. No significant differences in median levels of transcript at diagnosis were found between relapsing and non-relapsing patients (93,000 and 68,000; range: 86,000–103,000 and 37,000–116,000, respectively). Nine patients were analyzed after PBSCT: 3 persistently positive relapsed and the copy number of the transcript was always higher than at diagnosis. In the other 6 patients, the transcript was undetectable (3 of them were already in molecular remission pre-transplant): 5 are still in CCR while 1 patient relapsed 92 months after the graft. Regarding the FLT3-ITD status at diagnosis, 3/7 patients are in CCR whereas 4 have relapsed. The retention of NPM1 mutations even at relapse further confirms that NPM1 alterations are highly stable, pointing to this event as critical for leukemia growth and survival. Moreover, in our study long-term survival was always associated with a copy number of NPM1 mutant transcripts below the detectable level of the method, suggesting that disappearance of the transcript should be the primary clinical endpoint. Prospective studies and larger case series are necessary in an attempt to identify a cut-off level during treatment which could be predictive of the clinical outcome of AML patients harboring NPM1 mutations and help in therapeutic choices." @default.
• W2557974562 created "2016-12-08" @default.
• W2557974562 creator A5001112515 @default.
• W2557974562 creator A5001255651 @default.
• W2557974562 creator A5008077055 @default.
• W2557974562 creator A5014873864 @default.
• W2557974562 creator A5024919590 @default.
• W2557974562 creator A5031152745 @default.
• W2557974562 creator A5041322172 @default.
• W2557974562 creator A5046488049 @default.
• W2557974562 creator A5047898833 @default.
• W2557974562 creator A5070417705 @default.
• W2557974562 creator A5072698345 @default.
• W2557974562 creator A5080860305 @default.
• W2557974562 date "2008-11-16" @default.
• W2557974562 modified "2023-10-15" @default.
• W2557974562 title "Mlecular Monitoring of Acute Myeloid Leukemia Patients Carrying Nucleophosmin (NPM1) Mutations Undergoing An Autologous Peripheral Blood Stem Cell Transplantation" @default.
• W2557974562 doi "https://doi.org/10.1182/blood.v112.11.4864.4864" @default.
• W2557974562 hasPublicationYear "2008" @default.
• W2557974562 type Work @default.
• W2557974562 sameAs 2557974562 @default.
• W2557974562 citedByCount "0" @default.
• W2557974562 crossrefType "journal-article" @default.
• W2557974562 hasAuthorship W2557974562A5001112515 @default.
• W2557974562 hasAuthorship W2557974562A5001255651 @default.
• W2557974562 hasAuthorship W2557974562A5008077055 @default.
• W2557974562 hasAuthorship W2557974562A5014873864 @default.
• W2557974562 hasAuthorship W2557974562A5024919590 @default.
• W2557974562 hasAuthorship W2557974562A5031152745 @default.
• W2557974562 hasAuthorship W2557974562A5041322172 @default.
• W2557974562 hasAuthorship W2557974562A5046488049 @default.
• W2557974562 hasAuthorship W2557974562A5047898833 @default.
• W2557974562 hasAuthorship W2557974562A5070417705 @default.
• W2557974562 hasAuthorship W2557974562A5072698345 @default.
• W2557974562 hasAuthorship W2557974562A5080860305 @default.
• W2557974562 hasConcept C104317684 @default.
• W2557974562 hasConcept C126322002 @default.
• W2557974562 hasConcept C143998085 @default.
• W2557974562 hasConcept C174475383 @default.
• W2557974562 hasConcept C194409129 @default.
• W2557974562 hasConcept C2483381 @default.
• W2557974562 hasConcept C2777408962 @default.
• W2557974562 hasConcept C2778461978 @default.
• W2557974562 hasConcept C2778729363 @default.
• W2557974562 hasConcept C2779823535 @default.
• W2557974562 hasConcept C2780365373 @default.
• W2557974562 hasConcept C2911091166 @default.
• W2557974562 hasConcept C2994225774 @default.
• W2557974562 hasConcept C30481170 @default.
• W2557974562 hasConcept C501734568 @default.
• W2557974562 hasConcept C53226629 @default.
• W2557974562 hasConcept C54355233 @default.
• W2557974562 hasConcept C71924100 @default.
• W2557974562 hasConcept C86803240 @default.
• W2557974562 hasConcept C90924648 @default.
• W2557974562 hasConceptScore W2557974562C104317684 @default.
• W2557974562 hasConceptScore W2557974562C126322002 @default.
• W2557974562 hasConceptScore W2557974562C143998085 @default.
• W2557974562 hasConceptScore W2557974562C174475383 @default.
• W2557974562 hasConceptScore W2557974562C194409129 @default.
• W2557974562 hasConceptScore W2557974562C2483381 @default.
• W2557974562 hasConceptScore W2557974562C2777408962 @default.
• W2557974562 hasConceptScore W2557974562C2778461978 @default.
• W2557974562 hasConceptScore W2557974562C2778729363 @default.
• W2557974562 hasConceptScore W2557974562C2779823535 @default.
• W2557974562 hasConceptScore W2557974562C2780365373 @default.
• W2557974562 hasConceptScore W2557974562C2911091166 @default.
• W2557974562 hasConceptScore W2557974562C2994225774 @default.
• W2557974562 hasConceptScore W2557974562C30481170 @default.
• W2557974562 hasConceptScore W2557974562C501734568 @default.
• W2557974562 hasConceptScore W2557974562C53226629 @default.
• W2557974562 hasConceptScore W2557974562C54355233 @default.
• W2557974562 hasConceptScore W2557974562C71924100 @default.
• W2557974562 hasConceptScore W2557974562C86803240 @default.
• W2557974562 hasConceptScore W2557974562C90924648 @default.
• W2557974562 hasLocation W25579745621 @default.
• W2557974562 hasOpenAccess W2557974562 @default.
• W2557974562 hasPrimaryLocation W25579745621 @default.
• W2557974562 hasRelatedWork W1977397659 @default.
• W2557974562 hasRelatedWork W2038362765 @default.
• W2557974562 hasRelatedWork W2081230361 @default.
• W2557974562 hasRelatedWork W2123973137 @default.
• W2557974562 hasRelatedWork W2169183168 @default.
• W2557974562 hasRelatedWork W2242624189 @default.
• W2557974562 hasRelatedWork W2521195921 @default.
• W2557974562 hasRelatedWork W2561574407 @default.
• W2557974562 hasRelatedWork W2595081170 @default.
• W2557974562 hasRelatedWork W2887871213 @default.
• W2557974562 hasRelatedWork W2979679841 @default.
• W2557974562 hasRelatedWork W2984093197 @default.
• W2557974562 hasRelatedWork W3018482178 @default.
• W2557974562 hasRelatedWork W3035592857 @default.
• W2557974562 hasRelatedWork W3168879047 @default.
• W2557974562 hasRelatedWork W3184080661 @default.
• W2557974562 hasRelatedWork W3197777115 @default.
• W2557974562 hasRelatedWork W3201366107 @default.
• W2557974562 hasRelatedWork W3212818060 @default.
• W2557974562 hasRelatedWork W3213668150 @default.
• W2557974562 isParatext "false" @default.
• W2557974562 isRetracted "false" @default.

• next